rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes This patent enables rHEALTH’s unique technology to measure many analytes in a given small volume sample at home or in the clinic CAMBRIDGE, Mass., January 23, 2019 /PRWeb/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that...Read more
Recent Posts by DMI
Dr. Chan will present the rHEALTH technology at NASA's Human Research Program (HRP) Investigator's Workshop (IWS). The rHEALTH blood sensor is the subject of a NASA CCRPP contract to deliver comprehensive blood analysis capabilities for long-duration space travel. It is utilized in conjunction with the SKYE Sensor which enables comprehensive bioanalytical vitals information...Read more
CAMBRIDGE, Mass., Oct. 4, 2018 /PRNewswire-iReach/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/645,388, entitled “Sample Consumable and Loader” filed by its affiliate company, DNA Medicine Institute (DMI). This...Read more
Dr. Chan will be presenting a talk titled, "XPRIZE Tricorders and Point-of-Consumer Blood Diagnostics: Where are we now?" at the Athena Society, Corfu, Greece on September 8, 2018. http://athenasociety.org...Read more
CAMBRIDGE, Mass., Aug. 20, 2018 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, a digital health solutions company, today announced that the rHEALTH technology is a subject of NASA’s Civilian Commercial Readiness Pilot Program (CCRPP). Recipients of CCRPP awards must not only demonstrate maturation of technology that aligns with NASA interests, but also...Read more
Recent Comments by DMI
No comments by DMI yet.